Mhm. Baf et al., ALTERATIONS IN BRAIN REGIONAL MONOAMINE LEVELS AFTER CHRONIC ADMINISTRATION OF PHENOBARBITONE TO ADULT-RATS, Biogenic amines, 10(3), 1994, pp. 213-219
This study was undertaken to find out if the mechanism of action of ph
enobarbitone is mediated through monoamine alterations. Phenobarbitone
(60 mg/kg body weight) was administered to adult male Wistar rats by
intraperitoneal injections chronically for 45 days and the regional br
ain levels of norepienephrine (NE), dopamine (DA) and serotonin (5-HT)
were assayed using high performance liquid chromatographic (HPLC) met
hod. The phenobarbitone level in serum was within the effective antico
nvulsant concentration range. Phenobarbitone decreased NE levels in HI
(P < 0.01), HY (P < 0.05) and CB (P < 0.05), with no alterations in M
C, SA and BS regions. On the contrary, DA levels were increased in MC
(P < 0.001), SA (P < 0.05) and HY (P < 0.05) but decreased in BS (P <
0.001). Serotonin levels were decreased in MC (P < 0.05), HY (P < 0.01
) and BS (P < 0.001), while in SA, HI and CB, 5-HT levels did not diff
er from control rats. It appears that a given category of nerve termin
als might not be identically susceptible to phenobarbitone in differen
t regions of the brain. Phenobarbitone seems to exert its anticonvulsa
nt action by differentially altering monoamine levels in various brain
regions.